AVTX
#2490
Avalo Therapeutics, Inc. - Common Stock
18.5 5 USD
+0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.71%
Variación mensual
+28.73%
Variación en los últimos 6 meses
+26.71%
Cambio anual
+278.57%
Cierres anteriores
18.4 2
Open
18.5 5
Mínimo
18.5 5
High
18.5 5
Volumen
128
Financials
- Market Capitalization 975.09 M
- Employee 33
- Founded 2011
- CEO N/A
- Website www.avalotx.com
- Headquarter Delaware, United States
- FIGI BBG001QHW0Y8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.68
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2486 |  JANX Janux Therapeutics, Inc. - Common Stock | 16.03 USD | +1.58% | -3.20% | +16.41% | -41.04% | 977.58 M USD | ||
| 2487 |  LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 2.20 USD | +3.77% | -3.51% | +12.82% | +69.23% | 977.23 M USD | ||
| 2491 |  ANRO Alto Neuroscience, Inc. Common Stock | 27.76 USD | -0.29% | +4.48% | +27.69% | +920.59% | 974.21 M USD | ||
| 2510 |  SLDB Solid Biosciences Inc. - Common Stock | 9.62 USD | -0.10% | -12.31% | +35.30% | +68.77% | 947.09 M USD |